Skip to main content
Log in

Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The effects of 5-hydroxytryptamine (5-HT) receptor agonists on histamine turnover in mouse and rat brains were examined. The histamine turnover rate was estimated from the accumulation of tele-methylhistamine 90 min after i.p. injection of pargyline (65 mg/kg). In whole mouse brains, the histamine turnover was significantly inhibited by the 5-HT1A agonists, 8-hydroxy-2(di-n-propylamino)tetralin (8-OH-DPAT) (> 0.5 mg/kg) and buspirone (> 2 mg/kg) injected s. c. 10 min before pargyline treatment. 5-hydroxytryptophan (20 mg/kg) also significantly inhibited histamine turnover. Injections of the 5-HT1B agonist m-trifluoromethylphenylpiperazine (10 and 20 mg/kg) or the 5-HT2 agonist (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (1, 2 and 5 mg/kg)), however, did not affect histamine turnover. The inhibitory effect of 8-OH-DPAT (1 mg/kg) on histamine turnover was significantly antagonized (by 40%) by pindolol (20 mg/kg) and slightly antagonized (by 29%) by spiperone (10 mg/kg), while methysergide (20 mg/kg) and ketanserin (10 mg/kg) demonstrated no antagonistic effects. 8-OH-DPAT (0.3 and 1 mg/kg) also showed an inhibiting effect on histamine turnover in various regions of rat brains. Although the extent of inhibition was slightly larger in the striatum and cerebral cortex, there was no marked regional difference. These results suggest that histaminergic activity in the brain is regulated by 5-HT1A receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Alexander BS, Wood MD (1988) [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum. J Pharm Pharmacol 40:888–891

    Google Scholar 

  • Andrade R, Nicoll RA (1987) Novel anxiolytic discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 336:5–10

    Google Scholar 

  • Baba M, Nishibori M, Oishi R, Saeki K, Kosaka F (1987) Effects of halothane, enflurane and pentobarbital on brain histamine dynamics in mice. Naunyn-Schmiedeberg's Arch Pharmacol 335:686–691

    Google Scholar 

  • Bockaert J, Dumuis A, Bouhelal R, Sebben M, Cory RN (1987) Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons. Naunyn-Schmiedeberg's Arch Pharmacol 335:588–592

    Google Scholar 

  • DeVivo M, Maayani S (1986) Characterization of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J Pharmacol Exp Ther 238:248–253

    Google Scholar 

  • Eison AS, Eison MS, Stanley M, Riblet LA (1986) Serotonergic mechanisms in the behavioral effects of buspirone and gepirone. Pharmacol Biochem Behav 24:701–707

    Google Scholar 

  • Engel JA, Hjorth S, Svensson K, Carlsson A, Lindequist S (1984) Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 105:365–368

    Google Scholar 

  • Faingold CL (1978) Antihistaminics as central nervous system depressants. In: Rocha e Silva M (ed) Handbook of experimental pharmacology, vol 18, part 2. Histamine and anti-histaminics. Springer, Berlin Heidelberg New York, pp 561–571

    Google Scholar 

  • Gozlan H, ElMestikawy S, Pichat L, Glowinski J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305:140–142

    Google Scholar 

  • Gundelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulator responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology 25:1307–1313

    Google Scholar 

  • Gulat-Marnay C, Lafitte A, Arrang JM, Schwartz JC (1989) Regulation of histamine release and synthesis in the brain by muscarinic receptors. J Neurochem 52:248–254

    Google Scholar 

  • Gulat-Marnay C, Lafitte A, Arrang JM, Schwartz JC (1990) Modulation of histamine release in the rat brain by kappa-opioid receptors. J Neurochem 55:47–53

    Google Scholar 

  • Hamon M, Fattaccini CM, Adrien J, Gallissot MC, Martin P, Gozlan H (1988) Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potent anxiolytic properties. J Pharmacol Exp Ther 246:745–752

    Google Scholar 

  • Hill SJ, Straw RM (1988) α2-Adrenoceptor-mediated inhibition of histamine release from rat cerebral cortical slices. Br J Pharmacol 95:1213–1219

    Google Scholar 

  • Hjorth S, Magnusson T (1988) The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 338:463–471

    Google Scholar 

  • Hjorth S, Sharp T (1991) Effect of the 5-HT1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci 48:1779–1786

    Google Scholar 

  • Hough LB, Khandelwal JK, Green JP (1982) Effects of pargyline on tele-methylhistamine and histamine in rat brain. Biochem Pharmacol 31:4074–4076

    Google Scholar 

  • Hoyer D, Engel G, Kalkman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]-iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13–23

    Google Scholar 

  • Huston PH, Dourish CT, Curzon G (1988) Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. Eur J Pharmacol 150:361–366

    Google Scholar 

  • Itoh Y, Nishibori M, Oishi R, Saeki K (1985) Changes in histamine metabolism in the mouse hypothalamus induced by acute administration of ethanol. J Neurochem 45:1880–1885

    Google Scholar 

  • Itoh Y, Oishi R, Nishibori M, Saeki K (1987) Involvement of opioid receptors in phencyclidine-induced enhancement of brain histamine turnover in mice. Naunyn-Schmiedeberg's Arch Pharmacol 335:285–289

    Google Scholar 

  • Itoh Y, Oishi R, Nishibori M, Saeki K (1988) Involvement of mu receptors in the opioid-induced increase in the turnover of mouse brain histamine. J Pharmacol Exp Ther 244:1021–1026

    Google Scholar 

  • Itzhak Y, Ruhland M, Krähling H (1990) Binding of umespirone to the σ receptor: Evidence for multiple affinity states. Neuropharmacology 29:181–184

    Google Scholar 

  • Lin JS, Sakai K, Jouvet M (1988) Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacology 27:111–122

    Article  CAS  PubMed  Google Scholar 

  • Meller E, Goldstein M, Bohmaker K (1990) Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Mol Pharmacol 37:231–237

    Google Scholar 

  • Oishi R, Nishibori M, Saeki K (1983) Regional distribution of histamine and tele-methylhistamine in the rat, mouse and guinea-pig brain. Brain Res 280:172–175

    Google Scholar 

  • Oishi R, Nishibori M, Saeki K (1984) Regional differences in the turnover of neuronal histamine in the rat brain. Life Sci 34:691–699

    Google Scholar 

  • Oishi R, Itoh Y, Nishibori M, Saeki K (1985) Δ9-Tetrahydrocannabinol decreases turnover of brain histamine. J Pharmacol Exp Ther 232:513–518

    Google Scholar 

  • Oishi R, Nishibori M, Itoh Y, Saeki K (1986) Diazepam-induced decrease in histamine turnover in mouse brain. Eur J Pharmacol 124:337–342

    Google Scholar 

  • Oishi R, Itoh Y, Nishibori M, Saeki K (1987) Feeding-related circadian variation in tele-methylhistamine levels of mouse and rat brains. J Neurochem 49:541–547

    Google Scholar 

  • Oishi R, Adachi N, Okada K, Muroi N, Saeki K (1990) Regulation of histamine turnover via muscarinic and nicotinic receptors in the brain. J Neurochem 55:1899–1904

    Google Scholar 

  • Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain I. Serotonin-1 receptors. Brain Res 346:205–230

    Google Scholar 

  • Peroutka SJ (1986) Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C, binding sites in rat frontal cortex. J Neurochem 47:529–540

    Google Scholar 

  • Peroutka SJ (1987) Serotonin receptors. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 303–311

    Google Scholar 

  • Pollard H, Bischoff S, Schwartz JC (1973) Decreased histamine synthesis in the rat brain by hypnotics and anaesthetics. J Pharm Pharmacol 25:920–922

    Google Scholar 

  • Saeki K, Oishi R, Nishibori M, Itoh Y (1989) Effects of isofloxythepin on central and peripheral histamine systems. Jpn J Pharmacol 50:55–62

    Google Scholar 

  • Saeki K, Oishi R (1991) Turnover of neuronal histamine in the mammalian brain and its changes induced by drugs and observed in disease models. In: Watanabe T, Wada H (eds) Histaminergic neurons: morphology and function. CRC Press, Boca Raton, pp 345–363

    Google Scholar 

  • Schwartz JC, Garbarg M, Pollard H (1986) Histaminergic transmission in the brain. In: Bloom FE, Mountcastle VB, Geiger SR (eds) Handbook of physiology, Sect 1, vol 4. Intrinsic regulatory systems of the brain. American Physiological Society, Bethesda, pp 257–316

    Google Scholar 

  • Sharp T, Bramwell SR, Hijorth S, Grahame-Smith DG (1989) Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br J Pharmacol 98:989–997

    Google Scholar 

  • Shannon M, Battaglia G, Glennon RA, Titeler M (1984) 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2.5-dimenthoxyphenyl)2-aminopropane (2,5 DMA). Eur J Pharmacol 102:23–29

    Google Scholar 

  • Sprouse JS, Aghajanian GK (1986) (−)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol 128:295–298

    Google Scholar 

  • Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotonergic dorsal raphé neurons to 5-HT1A and 5-HT1B agonists. Synapse 1:3–9

    Google Scholar 

  • Tricklebank MD, Forler C, Fozard JR (1985) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106:271–282

    Google Scholar 

  • Tsuruta Y, Kohashi K, Ohkura Y (1981) Simultaneous determination of histamine and Nτ-methylhistamine in human urine and rat brain by high-performance liquid chromatography with fluorescence detection. J Chromatogr 224:105–110

    Google Scholar 

  • VandelMaelen CP, Matheson GK, Wilderman RC, Patterson LA (1986) Inhibition of serotonergic dorsal raphé neurons by systemic and iontophoretic administration of buspirone, a nonbenzodiazepine anxiolytic drug. Eur J Pharmacol 129:123–130

    Google Scholar 

  • Watanabe T, Taguchi Y, Shiosaka S, Tanaka J, Kubota H, Terano Y, Tohyama M, Wada H (1984) Distribution of the histaminergic neuron system in the central nervous system of rats: a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 295:13–25

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Send offprint requests to R. Oishi at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oishi, R., Roh, Y. & Saeki, K. Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 345, 495–499 (1992). https://doi.org/10.1007/BF00168939

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00168939

Key words

Navigation